SITC Cancer Immunotherapy CONNECT

SITC WIN LI 2023

Register Today for WIN LI

Aug. 8-9, 2024 in Chicago OR Aug. 22-23, 2024 Virtual
The Women in Cancer Immunotherapy Network (WIN) is a SITC initiative to promote and elevate women in the cancer immunotherapy field.


Applications are due by April 3, 2024, at 5 P.M. PST

Learn More

SITC Fellowships

Research Funding Available!

Apply by April 1, 2024

The SITC Forward Fund is pleased to offer five SITC Fellowships totaling $640,000 in funding. Get started on your application(s) now!

Learn More and Apply

SITC Fellowships

SITC's 2023 Year in Review

Delve into the myriad endeavors of 2023, available on SITC's new Year in Review website.

Visit the Website

2024 ACI Breast Cancers

2024 Advances in Cancer Immunotherapy: A Focus on Breast Cancers
March 29, 2024 | 1–5 P.M. ET | Live via Zoom Webinar

Join SITC and a panel of experts for an afternoon of in-depth education on all aspects of clinical implementation of immunotherapy for breast cancers. Program attendees will receive timely updates on the latest clinical advances in the field, including emerging combination therapies and immunotherapy for triple-negative breast cancer.

Learn More and Register

AI in IO.png

AI in IO: SITC-NCI Computational Immuno-oncology Webinar Series

SITC is pleased to announce its fourth SITC-NCI Computational Immuno-oncology Webinar Series.

This year's series will focus specifically on the application of artificial intelligence (AI) in the field of immuno-oncology (IO).

REGISTER NOW

Target for Cancer IO.png

Targets for Cancer IO: A Deep Dive Series

SITC is pleased to announce its fourth Targets for Cancer IO: A Deep Dive live webinar series.

At the time of registration, if you buy 4 webinars, you get the remaining 3 for free!

REGISTER NOW

Join SITC at the Society of Interventional Radiology 2024 Annual Meeting

View the latest advancements in interventional oncology and explore emerging IO therapies with SITC’s session at the SIR 2024 Annual Meeting March 25 in Salt Lake City, UT. Improve your patient centered care with cutting-edge technologies and gain insights from the best minds in the field!

Join or renew your SITC membership for 2024 and 2025 today.


Immunotherapy

Advances in Cancer Immunotherapy™ (ACI) Series

ACI programs are certified for CME, CNE, CPE, and MOC credits. ACI's offer in-depth clinical training in immunotherapy treatment for a variety of disease states and topics

Explore the 2024 ACI Series
SITC WIN 2024

Women in Cancer Immunotherapy Network

Aug. 8–9, 2024 in Chicago or virtual from Aug. 22–23, 2024

Applications for the in-person and virtual programs are due April 3, 2024, at 5 p.m. PST

Apply Today
SITC 2024 Fellowships

Research Funding Available

Apply by April 1, 2024

The SITC Forward Fund is pleased to offer five SITC Fellowships totaling $640,000 in funding. Get started on your application(s) now!

Learn More
SITC and IBCG

SITC and IBCG: Definitions, End Points, and Clinical Trial Designs for Bladder Cancer Webinar

March 18, 2024, from 4–5 P.M. CST

Join experts to discuss the publication in-depth, ask questions and explore topics such as: non-muscle and muscle invasive bladder cancer, metastatic unresectable and locally advanced disease.

Register Today
SITC Deep Dive

Targets for Cancer IO: 2024 Deep Dive - A Deep Dive into Personalized Vaccines

Live Webinar 1 Starts April 3 at 12 p.m. EDT

Key leaders in the field who are experts in their respective fields will provide an overview of the current state of the science and address questions about its future.

Join Today
SITC Deep Dive

SITC Immuno-oncology Drug Development Summit

Sept. 30 – Oct. 1, 2024 in Boston at The Revere Hotel Boston Common

The SITC Immuno-oncology Drug Development Summit will ensure that active, innovative new therapies are rapidly and appropriately moved into clinical testing.

Learn More

Making Cure a Reality

The Society for Immunotherapy of Cancer (SITC) is the world’s leading member-driven society dedicated to professionals working in the field of cancer immunotherapy.

It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.

Learn More

 Upcoming SITC Events


 Read the Latest SITC News

 Latest Discussions

  • Posted in: Women in SITC

    We're thrilled to unveil the faculty lineup for the upcoming 2024 SITC Women in #Cancer #Immunotherapy Network (WIN) Leadership Institute! Prepare to embark on a transformative ...

  • Hello! Attached are flyers for the Deep Dive Webinar Series and the Computational Immuno-oncology Webinar Series . Please share both with any colleagues that may be interested ...

  • Posted in: Women in SITC

    Apply for the 6 th Annual SITC Women in Cancer Immunotherapy Network (WIN) Leadership Institute with two opportunities to attend, in-person on Aug 8-9, 2024 in Chicago, IL ...

JITC Logo

An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.

Read the Journal

Ignite the SITC Sparkathon

Donate today to support early career scientists who are emerging leaders
seeking to advance research in the cancer immunotherapy field.

Learn More